Back to catalogue
№ 117 3 filings · 2023-09-27 → 2025-09-24

ECCLESIASTICAL INSURANCE OFFICE PLC

ELLA
Insurance Market cap £152m Overall fit 110 /1000

ELLA's listed paper is an 8.625% irredeemable preference share — a fixed-coupon income instrument with no AI exposure and no operating leverage to the holder; it is fairly priced as such, but is structurally outside the strategy this investor is running.

Fair value range 125p–160p Mid case · £152m
Absolute upside 0% vs current market cap
Conviction 4/5 confidence in fair call
Supports the call
  • Fixed, well-disclosed 8.625% perpetual coupon with consistent payment history
  • Strong Solvency UK cover (268%) and ~12x PBT coverage of dividend
  • Three filings + unqualified PwC review opinions across the period
Limits the call
  • Required market yield (5.5-7%) inferred from comparable UK insurer prefs, not disclosed in filings
  • Original preference share prospectus terms (covenants, any latent call features) not in these filings
Methodology

Yield capitalisation of perpetual preference dividend

In one line · bull case

ELLA is a well-covered ~6%-yielding perpetual preference share in a strongly capitalised UK specialty insurer, fairly priced for what it is.

In one line · biggest risk

Non-cumulative + irredeemable structure means any skipped dividend is permanent and any rise in required yield drives meaningful capital loss.

Drivers
AI beneficiary 8 /100
Specialist non-life insurer; no AI value-chain exposure, no AI-driven revenue line disclosed.
Operating leverage 8 /100
Fixed coupon to holder is invariant to underlying revenue; underlying insurer has only modest operating leverage either way.
Earnings vs expectations 50 /100
No analyst consensus or management guidance disclosed; 'not enough data' default of 50.
Growth momentum 60 /100
GWP +1.5% H1-25; UK+Ireland +6.9%; offset by Canada/Australia softness. Solid but not exciting.
Moat 45 /100
Niche specialist position in heritage/faith/charity insurance plus strong service awards; meaningful but narrow.
Earnings quality 70 /100
IFRS 17 reporting reviewed by PwC, unqualified; results swing with fair-value moves on equities, which is disclosed.
Management quality 65 /100
Long-serving CEO (Mark Hews), steady board renewal, consistent capital position; mission-driven (charitable owner) limits aggressive value-extraction risk.
Cyclicality 35 /100
Specialty book (heritage/charity/faith) is relatively defensive; weather and investment fair-value swings drive year-to-year volatility.
Leverage 25 /100
€30m subordinated debt only; NAV £644m, Solvency UK cover 268% — very low financial leverage at the issuer.

ECCLESIASTICAL INSURANCE OFFICE PLC (ELLA) — Research Note

Executive summary

Ecclesiastical is a specialist UK-headquartered general insurance group (heritage, charity, faith, education, high-net-worth, leisure) operating in the UK & Ireland, Canada and Australia, wholly owned by Benefact Group plc (ultimate parent: Benefact Trust, a charity). The ordinary equity is not publicly traded — the only listed instrument under the ELLA ticker is the 8.625% Non-Cumulative Irredeemable Preference share, which is effectively a perpetual fixed-coupon instrument. Across the three half-year filings (H1 2023 → H1 2025), the underlying insurer has materially improved: GWP £288m → £305m, COR 99.8% → 89.1%, profit before tax £10m → £55m, NAV £600m → £644m, Solvency 298%/254%/268% — all of which strengthen the safety of the preference dividend, but none of which flow through to upside for preference holders, whose return is capped at the fixed £9.2m annual coupon.

Fair value estimate

Methodology: yield-based valuation of a perpetual preference share. This is the only sensible approach — the £120.5m share capital line includes £106.4m nominal of 8.625% irredeemable prefs paying £9.18m per year (£4.59m every six months — confirmed in note 9 of all three filings). Ordinary equity (£14m nominal) is not listed; the £152.2m market cap therefore prices the preference paper, implying a running yield of ~6.0%.

Assumptions:

  • Annual dividend: £9.18m, perpetual, non-cumulative.
  • Coverage: covered ~6x by 2024 PBT (£82.5m) and ~12x by H1-25 underwriting+investment profit before corporate costs; Solvency UK ratio 268% 2025-09 half-year. Dividend safety is high.
  • Comparable UK insurer prefs (Aviva, Lloyds, GA) trade at 5.5–7.0% running yields for strong-balance-sheet issuers. Anchor a fair yield range of 5.5% (bull) to 7.0% (bear) for ELLA prefs.
  • Implied per-share fair value (8.625p annual coupon ÷ yield):
    • 5.5% → ~157p
    • 6.0% → ~144p
    • 7.0% → ~123p

Fair value range: ~125p to ~160p per preference share. Implied market-cap range: ~£133m to ~£170m. Mid-point ~£152m, essentially matching the current £152.2m mcap.

Upside vs. current £152.2m: range from −13% (bear yield widens to 7%) to +12% (bull yield compresses to 5.5%), mid-point ~0%. View: fair.

Sector context

Sector classification confirmed: Financials / Insurance (non-life specialist, with run-off life book for funeral plans). The underlying insurer has an above-average quality profile (strong solvency, consistent positive underwriting in UK/Canada, AM Best & Moody's stable, low net leverage, conservative investments) but the listed instrument is not a peer of conventional insurer equities — it's a fixed-income-like preference. Closest LSE-listed analogues are other irredeemable preference shares: Aviva 8.375% / 8.75% prefs, General Accident 7.875% / 8.875% prefs, Lloyds Banking 9.25% / 9.75% prefs. Underlying insurer peers would be Hiscox, Beazley, Lancashire and Direct Line — but those are equity stories ELLA holders do not participate in.

Investment thesis (3 bullets)

  • Very safe coupon, high-quality issuer. Solvency UK coverage 268% (up from 251%), NAV £644m sitting beneath the prefs, H1-25 PBT £54.5m covers the £9.2m annual dividend ~12x; Moody's/AM Best Stable ratings reaffirmed 2025-09 half-year. Dividend has been paid every period across all three filings.
  • Underlying business is genuinely improving. UK & Ireland GWP +6.9% H1-25 with COR of 86.9%, group COR consistently sub-90% in 2024 and H1-25 vs. 99.8% in H1-23; the parent's £250m "Grow to Give" target was hit early 2025-09 half-year; 2024-09 half-year. Stronger surplus = stronger preference-dividend coverage.
  • Yield premium relative to gilts. ~6% running yield on a UK regulated insurer with 268% solvency cover is a reasonable spread for a long-duration sterling income holding 2025-09 half-year, note 9.

Key risks (3 bullets)

  • Non-cumulative. If a dividend is ever skipped (a real option in stress, since coverage is reviewed against distributable reserves at each declaration date — confirmed in note 9 of all three filings), the holder permanently loses it. There is no make-up.
  • Irredeemable + interest-rate / credit-spread risk. Mark-to-market is highly duration-sensitive. The instrument has no maturity date and no call feature for the holder, so a 100bp rise in required yield from 6% to 7% is ~−13% on the price. Not disclosed but inferred from instrument terms.
  • Concentration of the issuer's economics with parent. Ecclesiastical paid a £20m ordinary dividend and a £33m charitable grant to Benefact in 2024, plus a further £20m ordinary dividend in H1-25 2025-09 half-year, statement of changes in equity. Distributions are at the discretion of the Benefact-controlled board; the preference holder relies on Benefact's willingness to keep enough capital in the insurance subsidiary to maintain solvency and dividend capacity. Not disclosed but inferred from cross-holding structure.

Operating leverage

For the listed preference share, operating leverage to the holder is effectively zero: the £9.2m coupon does not rise with revenue, underwriting profit, or investment return. Across H1-23 → H1-25, group PBT moved from £10m → £41m → £55m and the dividend was unchanged at £4.6m per half year. The improvement only translates into greater coverage of the existing fixed coupon, not into incremental cash to the holder. So in the framework asked for — where the user explicitly wants "incremental revenue drops disproportionately to profit, and profit accrues to me" — ELLA prefs fail the test by construction.

The underlying insurer itself has modest operating leverage: COR ranges from ~87% to ~92% across the cycle, expense ratio is broadly fixed, and a 10% premium beat at constant COR would lift underwriting profit ~10%. Investment-portfolio gearing means a strong year of fair-value gains (£37m in H1-25 vs. £10m H1-24) does flow through to PBT meaningfully 2025-09 half-year, note 7 — but none of that incremental profit reaches the preference holder.

Value-trap signals

None identified for the preference instrument itself. The underlying business is in good health (rising GWP, falling COR, rising solvency, strong ratings). The only structural caveat for the prefs is the non-cumulative + irredeemable feature, which is by design rather than a sign of distress.

Earnings vs. expectations

Ecclesiastical is a wholly-owned subsidiary that does not provide forward guidance and is not covered by sell-side analysts; no consensus or guidance numbers are referenced in any of the three filings. We therefore cannot judge "beats vs. misses" in the conventional sense. What we can observe directionally: 2023 was hit by St Mark's Church fire and adverse liability development (PBT £10m at H1-23); 2024 benefited from benign weather (PBT £41m at H1-24); 2025 absorbed Storms Darragh/Eowyn yet still grew PBT to £55m driven by stronger investment results. Underlying trajectory is positive but volatile around weather and investment fair-value moves. Score this driver "not enough data".

Conviction

4 — high. The methodology is unambiguous (income capitalisation of a known fixed coupon), the coupon is explicitly disclosed and historically paid, and three converging anchors — current implied yield, comparable insurer prefs, and dividend coverage — agree that the instrument trades near fair value.

Anchors of confidence: (a) coupon is fixed and disclosed; (b) capital cover and underwriting profitability are improving and well-documented; (c) PwC review opinions unqualified across all three periods. Limits: (a) the listed instrument's exact terms (call provisions, prospectus covenants) are not in these filings — they live in the original prospectus, which I have not read; (b) no comparable-yield matrix is given in-filing, so the 5.5–7.0% range is inferred from the wider UK preference-share market rather than from disclosed data.

Overall score for this investor profile

This is a fixed-coupon UK insurance preference share. It scores very poorly against the three pillars of the investor's brief: zero AI-receiver exposure, zero operating leverage to the holder, and (correctly) priced as fair income paper rather than offering meaningful upside. Its only attraction is downside protection — but the investor explicitly wants downside protection alongside AI-receiver upside and operating leverage, not as a substitute. Score band: 0-199 (poor fit) — not because the security is bad, but because it is a fundamentally different asset class from what the strategy targets.

Filings consulted · 3

Every document the LLM read for this note. Click any row to open the source.

  1. 2025-09-24Half Year Report2025-09-24_9127375_half-year-report.md0.77
  2. 2024-09-25Half Year Report2024-09-25_8437957_half-year-report.md0.58
  3. 2023-09-27Half Year Report2023-09-27_7779707_half-year-report.md0.41

This research note was authored by a large language model after reading 3 regulatory filings published between 2023-09-27 and 2025-09-24. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.